S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61

PetMed Express Stock Forecast, Price & News

-0.17 (-0.77%)
(As of 06/24/2022 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
447,915 shs
Average Volume
354,466 shs
Market Capitalization
$457.16 million
P/E Ratio
Dividend Yield
Price Target
30 days | 90 days | 365 days | Advanced Chart

Receive PETS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetMed Express and its competitors with MarketBeat's FREE daily newsletter.

PETS Stock Forecast (MarketRank)

Overall MarketRank

2.14 out of 5 stars

Retail/Wholesale Sector

145th out of 282 stocks

Drug Stores & Proprietary Stores Industry

4th out of 9 stocks

Analyst Opinion: 2.0Community Rank: 3.1Dividend Strength: 3.3Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
PetMed Express logo

About PetMed Express (NASDAQ:PETS)

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.

PETS Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Drug stores & proprietary stores
Internet Retail
Current Symbol
Year Founded

Company Calendar

Last Earnings
Ex-Dividend for 5/27 Dividend
Dividend Payable
Next Earnings (Estimated)
Fiscal Year End

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecasted Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
3 Analysts


Net Income
$21.10 million
Pretax Margin


Sales & Book Value

Annual Sales
$273.42 million
Cash Flow
$1.17 per share
Book Value
$6.78 per share


Free Float
Market Cap
$457.16 million

Social Links

PetMed Express Frequently Asked Questions

Should I buy or sell PetMed Express stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for PetMed Express in the last year. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" PetMed Express stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PETS, but not buy additional shares or sell existing shares.
View analyst ratings for PetMed Express
or view top-rated stocks.

What is PetMed Express' stock price forecast for 2022?

3 Wall Street research analysts have issued 12-month price targets for PetMed Express' stock. Their PETS stock forecasts range from $21.00 to $32.00. On average, they predict PetMed Express' share price to reach $27.00 in the next twelve months. This suggests a possible upside of 24.0% from the stock's current price.
View analysts' price targets for PetMed Express
or view top-rated stocks among Wall Street analysts.

How has PetMed Express' stock price performed in 2022?

PetMed Express' stock was trading at $25.26 at the beginning of the year. Since then, PETS stock has decreased by 13.8% and is now trading at $21.78.
View the best growth stocks for 2022 here

When is PetMed Express' next earnings date?

PetMed Express is scheduled to release its next quarterly earnings announcement on Monday, July 25th 2022.
View our earnings forecast for PetMed Express

How were PetMed Express' earnings last quarter?

PetMed Express, Inc. (NASDAQ:PETS) announced its quarterly earnings results on Monday, May, 9th. The company reported $0.30 EPS for the quarter, topping the consensus estimate of $0.27 by $0.03. The firm earned $66 million during the quarter, compared to analyst estimates of $67.80 million. PetMed Express had a net margin of 7.72% and a trailing twelve-month return on equity of 15.45%. During the same period in the previous year, the business earned $0.34 earnings per share.
View PetMed Express' earnings history

How often does PetMed Express pay dividends? What is the dividend yield for PetMed Express?

PetMed Express declared a quarterly dividend on Monday, May 9th. Stockholders of record on Friday, May 20th will be paid a dividend of $0.30 per share on Friday, May 27th. This represents a $1.20 annualized dividend and a dividend yield of 5.51%. The ex-dividend date of this dividend is Thursday, May 19th.
View PetMed Express' dividend history

Is PetMed Express a good dividend stock?

PetMed Express(NASDAQ:PETS) pays an annual dividend of $1.20 per share and currently has a dividend yield of 5.51%. PETS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. PetMed Express has been increasing its dividend for 13 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of PetMed Express is 115.39%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, PetMed Express will have a dividend payout ratio of 110.09% in the coming year. This indicates that PetMed Express may not be able to sustain their current dividend.
View PetMed Express' dividend history.

Who are PetMed Express' key executives?

PetMed Express' management team includes the following people:
  • Mr. Bruce S. Rosenbloom, CFO & Treasurer (Age 53, Pay $473.47k) (LinkedIn Profile)
  • Mr. Matthew N. Hulett, CEO, Pres & Director (Age 51)
  • Mr. Mark Moseley, Chief Technology & Information Officer
  • Mr. Daniel Job Pingree, Chief Marketing Officer
  • Ms. Jacqueline Smith, VP of People
  • Wendy Zalai, Corp. Controller & Corp. Sec.

What is Mendo Akdag's approval rating as PetMed Express' CEO?

5 employees have rated PetMed Express CEO Mendo Akdag on Glassdoor.com. Mendo Akdag has an approval rating of 46% among PetMed Express' employees. This puts Mendo Akdag in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of PetMed Express' key competitors?

What other stocks do shareholders of PetMed Express own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PetMed Express investors own include Intel (INTC), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Alibaba Group (BABA), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Verizon Communications (VZ), Netflix (NFLX) and Micron Technology (MU).

What is PetMed Express' stock symbol?

PetMed Express trades on the NASDAQ under the ticker symbol "PETS."

Who are PetMed Express' major shareholders?

PetMed Express' stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (15.91%), Vanguard Group Inc. (6.85%), Renaissance Technologies LLC (4.64%), ProShare Advisors LLC (4.36%), State Street Corp (4.35%) and Dimensional Fund Advisors LP (2.70%). Company insiders that own PetMed Express stock include Bruce S Rosenbloom, Gian Fulgoni, Menderes Akdag and Ronald J Korn.
View institutional ownership trends for PetMed Express

Which major investors are selling PetMed Express stock?

PETS stock was sold by a variety of institutional investors in the last quarter, including J. Goldman & Co LP, State Street Corp, Group One Trading L.P., Penserra Capital Management LLC, ProShare Advisors LLC, Allianz Asset Management GmbH, Bahl & Gaynor Inc., and Simplex Trading LLC. Company insiders that have sold PetMed Express company stock in the last two years include Bruce S Rosenbloom, Gian Fulgoni, Menderes Akdag, and Ronald J Korn.
View insider buying and selling activity for PetMed Express
or view top insider-selling stocks.

Which major investors are buying PetMed Express stock?

PETS stock was acquired by a variety of institutional investors in the last quarter, including Mirae Asset Global Investments Co. Ltd., Mirae Asset Global Investments Co. Ltd., Renaissance Technologies LLC, Goldman Sachs Group Inc., Walleye Trading LLC, BlackRock Inc., Charles Schwab Investment Management Inc., and Fisher Asset Management LLC.
View insider buying and selling activity for PetMed Express
or or view top insider-buying stocks.

How do I buy shares of PetMed Express?

Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PetMed Express' stock price today?

One share of PETS stock can currently be purchased for approximately $21.78.

How much money does PetMed Express make?

PetMed Express (NASDAQ:PETS) has a market capitalization of $457.16 million and generates $273.42 million in revenue each year. The company earns $21.10 million in net income (profit) each year or $1.039990 on an earnings per share basis.

How many employees does PetMed Express have?

PetMed Express employs 219 workers across the globe.

When was PetMed Express founded?

PetMed Express was founded in 1996.

How can I contact PetMed Express?

PetMed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The official website for PetMed Express is www.1800petmeds.com. The company can be reached via phone at (561) 526-4444, via email at [email protected], or via fax at 561-526-4445.

This page (NASDAQ:PETS) was last updated on 6/26/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.